Results 181 to 190 of about 3,362,668 (327)

Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE‐BD Cohort

Acta Psychiatrica Scandinavica, Volume 153, Issue 2, Page 108-121, February 2026.
ABSTRACT Introduction Metabolic syndrome (MetS) has been suggested to be associated with cognitive impairments in bipolar disorder (BD); however, studies are limited by small sample sizes or cross‐sectional design. Our objective is to evaluate the cross‐sectional and longitudinal associations between MetS and cognitive performances in a large cohort of
I. Palimaru, B. Etain, M. Leboyer, Y. Dansou, P. Favre, S. Gard, V. Aubin, F. Bellivier, R. Belzeaux, P. Courtet, C. Dubertret, E. Haffen, A. Lefrere, P. M. Llorca, E. Olié, M. Polosan, L. Samalin, R. Schwan, the FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE‐BD) Collaborators, B. Etain, E. Olié, M. Leboyer, E. Haffen, P. M. Llorca, V. Barteau, S. Bensalem, O. Godin, H. Laouamri, K. Souryis, S. Hotier, A. Pelletier, F. Hergeta, J. Petrucci, L. Willaume, F. Bellivier, B. Etain, V. Hennion, E. Marlinge, J. Meheust, A. Richard, M. Carminati, H. Francisque, S. Gard, K. M’Bailara, C. Elkael, F. Hoorelbeke, I. Minois, J. Sportich, N. Da Ros, C. Dubertret, N. Mazer, C. Portalier, C. Scognamiglio, A. Bing, P. Laurent, L. Boukhobza, P. Courtet, S. Denat, B. Deffinis, D. Ducasse, M. Gachet, A. Lengvenyté, F. Molière, L. Nass, E. Olié, G. Tarquini, A. Lefrere, E. Moreau, J. Pastol, F. Groppi, H. Polomeni, J. Bauberg, L. Lescalier, I. Muraccioli, A. Suray, R. Cohen, J. P. Kahn, M. Milazzo, O. Wajsbrot‐Elgrabli, T. Bougerol, A. Pouchon, A. Bertrand, B. Fredembach, A. Suisse, Q. Denoual, M. Polosan, A. M. Galliot, L. Brehon, G. Bonny, L. Durand, V. Feuga, N. Kayser, P. Roux, V. Aubin, I. Cussac, M. A. Dupont, J. Loftus, I. Medecin, C. Dubertret, N. Mazer, P. Laurent, L. Samalin, P. M. Llorca, M. Mennetrier, T. Bonnet, D. Lacelle, M. Vayssié, C. Beal, O. Blanc, P. Roux, O. Godin   +110 more
wiley   +1 more source

A Roadmap for Development of Novel Antipsychotic Agents Based on a Risperidone Scaffold

, 2017
Urjita H. Shah
openalex   +2 more sources

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review

Acta Psychiatrica Scandinavica, Volume 153, Issue 2, Page 95-107, February 2026.
ABSTRACT Introduction Posttraumatic stress disorder (PTSD) is a mental disorder resulting from exposure to traumatic events. Evidence suggests that ketamine may be efficacious in treating PTSD, however, ketamine's mechanisms in treating PTSD remain unclear. Herein, this review aims to evaluate the clinical outcomes of ketamine treatment in persons with
Liyang Yin, Andy Lu, Gia Han Le, Christine E. Dri, Sabrina Wong, Kayla M. Teopiz, Heidi Xu, Roger Ho, Taeho Greg Rhee, Heidi Ka Ying Lo, Maria‐Christina Sioufi, Yang Jing Zheng, Hezekiah C. T. Au, Hernan F. Guillen‐Burgos, Bing Cao, Roger S. McIntyre   +15 more
wiley   +1 more source

Rational antipsychotic polypharmacy in psychotic and bipolar disorders: A focus on D2 receptor partial agonists. [PDF]

Ment Health Clin
Salwan A.
europepmc   +1 more source

Attitudes of patients towards mental health nurse prescribing of antipsychotic agents.

International Journal of Nursing Practice, 2008
T. McCann, E. Clark
semanticscholar   +1 more source

Knowledge and Confidence in Psychotropic Prescribing, Utilisation of Guidelines and Resources in Managing Perinatal Mental Health in General Practice: An Australian Cross‐Sectional Survey

Australian Journal of Rural Health, Volume 34, Issue 1, February 2026.
ABSTRACT Objective Management of psychiatric disorders in the perinatal period is a common presentation in primary care. There is a need to understand how general practitioners (GPs) use guidelines and resources and incorporate the knowledge within clinical practice.
Jacqueline Frayne, Sarah Seddon, Tamara Lebedevs, Talila Milroy, Beverly Teh, Thinh Nguyen   +5 more
wiley   +1 more source

Antipsychotic Misuse: A Silent but Growing Public Health Hazard. [PDF]

Cureus
Bhardwaj S, Pathak K, McLenon M, Spector S, Tu K.   +4 more
europepmc   +1 more source

A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 2, February 2026.
ABSTRACT To address challenges in deprescribing, we investigated the feasibility of an intervention consisting of a clinical medication review (CMR) focused on deprescribing, supported by a training programme for healthcare providers (HCPs) among older patients with hyperpolypharmacy (≥ 10 chronic medications) in primary care.
Gert Baas, Mette Heringa, Sanne Verdoorn, Henk‐Frans Kwint, Eman Badawy, Jacobijn Gussekloo, Marcel Bouvy   +6 more
wiley   +1 more source

Gaps in the detection of drug-drug interactions between antipsychotic and cardiometabolic medications: a multisource analysis. [PDF]

BMC Med
Yao H, Peng Z, Huang Y, Xiao S, Wu R.
europepmc   +1 more source

Advancing the measurement of psychotherapy outcomes for youth with irritability using in vivo ecological momentary assessment: an exploratory observational study

Child and Adolescent Mental Health, Volume 31, Issue 1, Page 33-40, February 2026.
Background Ecological momentary assessment (EMA) can reveal naturalistic within‐person changes in symptoms and behaviors, essential for examining psychotherapy's effectiveness. However, no prior study has leveraged EMA to assess real‐time, naturalistic changes of clinical symptoms during psychotherapy in youth with clinically impairing irritability ...
Reut Naim, Urmi Pandya, Shannon Shaughnessy, Ramaris E. German, Lauren M. Henry, Katharina Kircanski, Melissa A. Brotman   +6 more
wiley   +1 more source